Intensive glucose lowering in type 2 diabetes
20 results
1 - 20Intensive glucose lowering in type 2 diabetes
Intensive glucose lowering does not benefit patients with type 2 diabetes
Tight glycemic control doesn't decrease ischemic heart disease events (ACCORD)
Long-term follow-up confirms lack of mortality benefit of strict blood sugar control in T2DM
Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
Intensive glucose control slightly lowers quality of life scores (ACCORD)
Bariatric surgery plus intensive medical therapy better than medical therapy alone for diabetes (STAMPEDE)
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus New search for studies and content updated (conclusions changed)
Intensive glucose control increases mortality in T2DM (ACCORD)
Detrimental effect of tight glucose control on CV mortality persists over 9 years
USPSTF recommends screening for diabetes in hypertensive patients
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus New
Glucose targets for preventing diabetic kidney disease and its progression New
Comprehensive treatment and follow-up of type 2 diabetes
BP target of 120 no better than 140 in T2DM (ACCORD)
Blood pressure control for diabetic retinopathy: Cochrane systematic review